Author

Molly Parrish

University of North Carolina at Chapel Hill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Cyrus VaziriiD· 1 shared Emily M. RabjohnsiD· 1 shared Gaith N. DrobyiD· 1 shared Hannah N. LeeiD· 1 shared Jessica L. BowseriD· 1 shared Katherine C. KurnitiD· 1 shared Lilly F. ChiouiD· 1 shared Rebecca M. HirschiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cyrus VaziriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas

Rebecca M. Hirsch, Gaith N. Droby, Sunthoshini Premsankar, Molly Parrish, Katherine C. Kurnit, Lilly F. Chiou, Emily M. Rabjohns, Hannah N. Lee, Russell R. Broaddus, Cyrus Vaziri, Jessica L. Bowser

This paper identifies CD73 as a regulator that limits oncogenic activity of mutant β-catenin in endometrial carcinomas, showing that its loss increases transcriptional activity and tumor progression.

JCI Insight · Jan 22, 2026Peer-reviewedCancer Biology